Actemra subcutaneous injection 162 mg autoinjector, from Chugai Pharmaceutical, features Tocilizumab (genetically recombination). This injectable drug (YJ code: 6399421G2029) is supplied as 162mg in 0.9mL per kit and is utilized for conditions such as active moderate to severe rheumatoid arthritis and systemic juvenile idiopathic arthritis.
Actemra subcutaneous injection 162 mg autoinjector
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →